Do Arteriovenous Malformations (AVMs) pose a risk for the development of aneurysms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Association Between AVMs and Aneurysms

Yes, arteriovenous malformations (AVMs) are significantly associated with aneurysms, with approximately 7-23.5% of AVM patients harboring associated aneurysms, which substantially increases hemorrhage risk and mortality. 1, 2, 3

Epidemiology and Classification

The association between AVMs and aneurysms is well-documented in the medical literature:

  • Approximately 7-17% of AVM patients have associated intracranial aneurysms according to the American Stroke Association guidelines 1
  • More recent studies report even higher rates:
    • 23.5% of AVM patients had associated aneurysms in a large series of 366 patients 2
    • A systematic review of 10,093 AVMs found that 20.2% harbored associated aneurysms 4

Types of AVM-Associated Aneurysms

Associated aneurysms can be categorized based on their location relative to the AVM:

  • Feeding artery aneurysms (flow-related)
  • Intranidal aneurysms (within the AVM nidus)
  • Unrelated aneurysms (typically on the circle of Willis)

Clinical Significance and Hemorrhage Risk

The presence of aneurysms significantly increases the hemorrhage risk in AVM patients:

  • In patients with both AVMs and aneurysms who present with hemorrhage, the aneurysm is the bleeding source in approximately 49.2% of cases 4
  • Flow-related aneurysms are the most common source of hemorrhage (78.5%) among ruptured AVM-associated aneurysms 4
  • Female patients with AVMs and associated aneurysms have a significantly higher risk of hemorrhage (odds ratio 8.53) 3
  • Location matters: infratentorial AVM-associated aneurysms have a higher rupture risk (60%) compared to supratentorial lesions (29%) 4

Management Considerations

Given the increased hemorrhage risk, management of AVM-associated aneurysms requires special consideration:

  • The American Stroke Association recommends that associated aneurysms be treated during the same surgery if the operative field is adequate, or separately with endovascular or open surgical obliteration 1
  • Treatment priority should be given to the aneurysm before AVM treatment to reduce the risk of hemorrhage during or immediately after AVM treatment 3
  • Treatment options include:
    • Endovascular coiling
    • Surgical clipping
    • Embolization with liquid agents (NBCA or Onyx)

Treatment Outcomes

  • Endovascular treatment of AVM-associated aneurysms has shown:
    • 80% cure rate
    • 8.7% complication rate
    • 78.8% good neurological outcome rate 4
  • However, if the AVM is not completely obliterated, there is a significant recurrence rate (37.5%) of treated aneurysms after endovascular coiling 5

Pitfalls and Special Considerations

  • New aneurysms may develop in patients with high-flow AVMs, necessitating long-term follow-up 3
  • Aneurysms can rupture before, during, or immediately after AVM treatment 3
  • Meticulous blood pressure control during aneurysm surgery is critical to avoid hemorrhage from the AVM 3
  • In cases of incomplete AVM obliteration, treated aneurysms should be closely monitored due to the risk of recurrence 5

Conclusion

The evidence clearly demonstrates that AVMs pose a significant risk for the development of aneurysms. These associated aneurysms substantially increase the risk of hemorrhage and should be addressed as part of the comprehensive management strategy for AVM patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.